Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fitstry vs Tyde Wellness

By GLP-1 ScorecardUpdated

Fitstry
Site position #329

Lower grade

Tyde Wellness
Site position #40

Higher grade

Score comparison

Tyde Wellness has the higher recorded score — 79.8/100 to 61.5/100.

Tyde Wellness grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Tyde Wellness is a 50-state compounded-GLP-1 and longevity telehealth platform spanning weight loss, HRT, hair, and peptides.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTyde Wellness +56
30
86
Dose & formulationTyde Wellness +8
75
83
Clinical oversightTyde Wellness +8
81
89
Labs & monitoringFitstry +19
73
54
FulfillmentTyde Wellness +24
67
91
Contract termsTyde Wellness +14
47
61
Fitstry · top barTyde Wellness · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFitstryTyde Wellness
WeighScore61.5/10079.8/100
GradeCC+
Site position#329#40
Semaglutide$179/mo (annual plan, plus a separate fee, compounded)$149/mo (microdose tier, all doses, compounded)
Tirzepatide$269/mo (annual plan, compounded)$249/mo (microdose tier, all doses, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
Fitstry

Site position #329 · C

Strengths

  • Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
  • Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
  • Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
  • Runs under Weightstry, LLC, a LegitScript-certified practice, with a named support email and phone
  • Full compounded lineup — weekly injection, daily oral tablet and microdosing options

What to consider

  • Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Framed for women 40+, and serves 49 states rather than all 50 (the excluded state isn't disclosed publicly)
  • Works with state-licensed compounding pharmacies but doesn't name a specific pharmacy partner on the Fitstry page
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name
Tyde Wellness

Site position #40 · C+

Strengths

  • All 50 states served (full list published)
  • Transparent pricing: semaglutide from $149/mo, tirzepatide from $249/mo
  • LegitScript Certified with a verification link
  • Five named 503A pharmacy partners with addresses: Belmar (CO), Casa (TX), Olympia (FL), Red Rock (UT), Beaker (TX)
  • Free consultation; cancel-anytime subscription with no long-term commitment

What to consider

  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No brand-name GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic)
  • Tirzepatide priced higher than competitors offering $200-$249/mo
  • Corporate address and medical director not publicly disclosed
  • No NABP.pharmacy seal visible

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard